Postpartum Hemorrhage Devices Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2015 to 2020 and Forecast 2021 to 2027

$ PRICE - $ 3,000.00$ 8,900.00

Global Postpartum Hemorrhage Devices Market By Product Type (Uniject Prefilled Injection System, Non-Pneumatic Anti-Shock Garment, Uterine Balloon Tamponade, Condom Catheter, Foley Catheter, Rusch Balloon, Others), End Users (Hospitals, Maternity Clinics, Others), and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

The global Postpartum Hemorrhage Devices Market valued at USD 840 Mn by 2021 expected to reach USD 1166 Mn by 2028 growing at a CAGR of 4.8% during the forecast period 2022 to 2028. Postpartum Hemorrhage (PPH) is an obstetric hemorrhagic condition that is a prime reason for maternal mortality. In postpartum hemorrhagic condition patient loss about 500mL blood in vaginal delivery or approximately 1000mL blood after cesarean delivery. It is categorized into two types namely, primary postpartum hemorrhage and secondary postpartum hemorrhage. Rising pregnancy difficulties such as multiple pregnancies, tilted uterus, and large baby size are significant factors for the Postpartum Hemorrhage Devices Market expansion. Furthermore, rising postpartum haemorrhage risk factors such as uterine atony, trauma, and anaemia cases in pregnant women, as well as technological advancements such as the devices’ ability to stabilise the patient’s condition until permanent treatment is provided, are propelling the PPH devices market forward. The lack of healthcare resources in poor nations, as well as the expensive cost of equipment, are projected to stifle the market for postpartum haemorrhage (PPH) devices. One of the causes of postpartum haemorrhage in pregnant women is anaemia, a major nutritional condition. According to research published by the National Center for Biotechnology Information in 2008, severe anaemia can damage the immune system, contributing to postpartum haemorrhage. PPH can be treated with first-line (non-surgical) techniques such as the use of uterotonic medicines like oxytocin and misoprostol. Second-line intervention devices, such as non-pneumatic anti-shock garments, uterine balloon tamponade, and Uniject prefilled injectable systems, are used when medications are not available. Because these devices are successful in stopping blood flow and stabilising the patient’s condition until more comprehensive care is delivered.

Postpartum Hemorrhage Devices Market

MARKET SUMMARY
-
4.8% CAGR
  • Study Period– 2022-2028
  • Base Year– 2021
  • CAGR– 4.8%
  • Largest Market– North America
  • Fastest Growing Market– Europe

Postpartum Hemorrhage Devices Market

  • The report on global Postpartum Hemorrhage Devices Market gives historical, current, and future market sizes (US$ Mn) on the basis of product type, end user and geography.
  • Postpartum Hemorrhage Devices Market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa
Key Players
  • R. Bard, Inc. (U.S.)
  • Becton, Dickinson, and Company (U.S.)
  • Cook Medical, Inc. (U.S.)
  • Utah Medical Products, Inc. (U.S.)
  • Bactiguard AB (Bactiguard Holding) (Sweden)
Dynamics

Postpartum Hemorrhage Devices Market

Increase in the incidence of pregnancy complication cases like multiple pregnancies, baby size and inverted uterus, rise in risk factors like trauma, uterine atony, rise in anemia in pregnant woman, growing support from healthcare organizations, and technology advancements in the devices are anticipated to fuel the postpartum hemorrhage devices market. However, stringent regulations for postpartum hemorrhage device approval, lack of awareness about devices in underdeveloped countries, high cost of devices, and dearth of well-trained professionals may restrain the growth of postpartum hemorrhage devices market over the forecast period.


North-America got significant share

Postpartum Hemorrhage Devices Market

Geographically, global postpartum hemorrhage devices market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa regions. North America is growing at a significant rate owing to high adoption of advanced medical devices, sophisticated healthcare infrastructure, and presence of huge number of device manufacturers in the region. Europe has a lucrative growth due to increase in complicated pregnancy cases, high incidence of anemia, severe preeclampsia, and postpartum hemorrhage in women, and high awareness about postpartum hemorrhage devices among healthcare professionals are bolster the market. Asia Pacific is poised to grow due to rise in demand for postpartum hemorrhage devices in China due to policy change from single child policy to two children policy, increase in postpartum hemorrhage cases in South Korea, and sophisticated healthcare infrastructure in Japan are expected to boost the market. Latin America growth attributed to increase in pre-mature labors in Brazil, rise in prevalence of postpartum hemorrhage cases, and expansion of business by the market players in the region. Middle East and Africa postpartum hemorrhage devices market is poised to grow at significant rate due rise in prevalence of obstetric hemorrhage owing to abruption placenta, uterine rupture, and uterine trauma, prolonged third stage of labor and multiple gestations in Saudi Arabia women are expected to propel the market growth.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market and forecast
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Postpartum Hemorrhage Devices Market Segmentation


Location

GEOGRAPHY


Report

Table Of Content


Report

Company Profile

  • R. Bard, Inc. (U.S.)
  • Becton, Dickinson, and Company (U.S.)
  • Cook Medical, Inc. (U.S.)
  • Utah Medical Products, Inc. (U.S.)
  • Bactiguard AB (Bactiguard Holding) (Sweden)
  • Teleflex Incorporated (U.S.)
  • 3RD Stone Design, Inc. (U.S.)
  • Zoex Niasg (U.S.)
  • Revmedx Inc. (U.S.)
  • Clinical Innovations, LLC (U.S.)
  • Inpress Technologies (U.S.)

Description

The global Postpartum Hemorrhage Devices Market valued at USD 840 Mn by 2021 expected to reach USD 1166 Mn by 2028 growing at a CAGR of 4.8% during the forecast period 2022 to 2028. Postpartum Hemorrhage (PPH) is an obstetric hemorrhagic condition that is a prime reason for maternal mortality. In postpartum hemorrhagic condition patient loss about 500mL blood in vaginal delivery or approximately 1000mL blood after cesarean delivery. It is categorized into two types namely, primary postpartum hemorrhage and secondary postpartum hemorrhage. Rising pregnancy difficulties such as multiple pregnancies, tilted uterus, and large baby size are significant factors for the Postpartum Hemorrhage Devices Market expansion. Furthermore, rising postpartum haemorrhage risk factors such as uterine atony, trauma, and anaemia cases in pregnant women, as well as technological advancements such as the devices’ ability to stabilise the patient’s condition until permanent treatment is provided, are propelling the PPH devices market forward. The lack of healthcare resources in poor nations, as well as the expensive cost of equipment, are projected to stifle the market for postpartum haemorrhage (PPH) devices. One of the causes of postpartum haemorrhage in pregnant women is anaemia, a major nutritional condition. According to research published by the National Center for Biotechnology Information in 2008, severe anaemia can damage the immune system, contributing to postpartum haemorrhage. PPH can be treated with first-line (non-surgical) techniques such as the use of uterotonic medicines like oxytocin and misoprostol. Second-line intervention devices, such as non-pneumatic anti-shock garments, uterine balloon tamponade, and Uniject prefilled injectable systems, are used when medications are not available. Because these devices are successful in stopping blood flow and stabilising the patient’s condition until more comprehensive care is delivered.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX